GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKKGY) » Definitions » Investments And Advances

MKKGY (Merck KGaA) Investments And Advances : $0 Mil (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Merck KGaA Investments And Advances?

Merck KGaA's Investments And Advances for the quarter that ended in Dec. 2024 was $0 Mil.


Merck KGaA Investments And Advances Historical Data

The historical data trend for Merck KGaA's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Investments And Advances Chart

Merck KGaA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Merck KGaA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Merck KGaA Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Merck KGaA Business Description

Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA Headlines

From GuruFocus

Q3 2024 Merck KGaA Earnings Call Transcript

By GuruFocus News 11-15-2024

Merck KGaA Capital Markets Day Transcript

By GuruFocus Research 02-14-2024

Q3 2022 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Merck KGaA Capital Markets Day (Virtual) Transcript

By GuruFocus Research 02-14-2024

Merck KGaA R&D Update Call Transcript

By GuruFocus Research 02-14-2024

Q4 2024 Merck KGaA Earnings Call Transcript

By GuruFocus News 03-07-2025

Q3 2023 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Merck KGaA Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024